EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bioimpedance and Symptom Guided Fluid Management in Hemodialysis: A Multicenter Pre–Post Implementation Study

Maaike Nielen, Maria K Svensson iD, Hans Furuland iD, Ursa Bonnevier iD, Ainhoa Indurain iD, Annica Sedin iD, Michael Eklund iD, Jenny Stenberg iD

Hemodialysis International · 05.07.2026

DOI: 10.1111/hdi.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hemodialysis International, online erschienen am 05.07.2026. Verfasst von Maaike Nielen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Renal Medicine, Uppsala University, Uppsala, Sweden. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uppsala Universitet, Stiftelsen för Njursjukas förening i CUWX-länens forskningsfond - a regional kidney patients' association representing Uppsala and Västmanland counties within…, Sweden and Stiftelsen för Njursjuka (the Foundation for Kidney Patients), Sweden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Optimizing volume status is central to hemodialysis care and may influence patient‐reported outcome measures as recovery time. We evaluated the implementation of a structured decision aid (Recova) integrating symptom assessment with bioimpedance spectroscopy in routine hemodialysis practice.

Methods

A prospective multicenter pre–post within‐subjects study was conducted in 10 Swedish hemodialysis clinics. Clinics adopted the intervention on a staggered schedule based on local readiness. Participants were assessed at baseline and after 12 weeks. Outcomes included bioimpedance spectroscopy‐derived overhydration and extracellular water, patient‐reported recovery time (hours to resume usual activities), and a fluid‐related symptom score. Paired measurements were compared.

Results

Of 404 screened patients, 129 consented and 123 initiated the intervention. Recovery time data were available at both time points for 110 participants. Overhydration decreased from 2.6 ± 1.7 to 2.3 ± 2.0 L ( p = 0.04) and extracellular water from 18.4 ± 4.0 to 18.0 ± 3.8 L ( p = 0.01). Mean recovery time did not change significantly (6.7 ± 7.1 to 5.8 ± 6.2 h; p = 0.22) and median recovery time remained 4 h (IQR 1–10). Fluid‐related symptom burden declined over the intervention period. No harms were reported; 13 participants did not complete the 12‐week intervention.

Conclusions

In this multicenter pre–post evaluation, implementation of Recova was associated with modest improvements in bioimpedance spectroscopy‐derived volume metrics and fluid‐related symptoms, while recovery time did not change significantly. Controlled studies are needed to determine effectiveness and to identify which patients may benefit.

Schlagwörter

Stichwörter der Autor:innen

bioimpedance spectroscopyclinical decision supportfluid managementhemodialysispatient‐reported outcomesrecovery time

Autor:innen und Institutionen

  • Department of Medical Sciences, Renal Medicine, Uppsala University, Uppsala, Sweden.
  • Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Department of Nephrology, Gävle Hospital, Gävle, Sweden.
  • Department of Nephrology and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
  • Department of Nephrology, Karlskoga Hospital, Karlskoga, Sweden.
  • Department of Internal Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

ORCID-Profile: Maria K Svensson, Hans Furuland, Ursa Bonnevier, Ainhoa Indurain, Annica Sedin, Michael Eklund, Jenny Stenberg

Förderung

  • Uppsala Universitet
  • Stiftelsen för Njursjukas förening i CUWX-länens forskningsfond - a regional kidney patients' association representing Uppsala and Västmanland counties within…
  • Sweden and Stiftelsen för Njursjuka (the Foundation for Kidney Patients), Sweden
  • Regionala Forskningsrådet Uppsala/Örebro

Zitieren

APA

Nielen, M., Svensson, M. K., Furuland, H., Bonnevier, U., Indurain, A., Sedin, A., Eklund, M., & Stenberg, J. (2026). Bioimpedance and Symptom Guided Fluid Management in Hemodialysis: A Multicenter Pre–Post Implementation Study. Hemodialysis International. https://doi.org/10.1111/hdi.70109

Vancouver

Nielen M, Svensson MK, Furuland H, Bonnevier U, Indurain A, Sedin A, et al. Bioimpedance and Symptom Guided Fluid Management in Hemodialysis: A Multicenter Pre–Post Implementation Study. Hemodialysis International. 2026. doi:10.1111/hdi.70109

BibTeX
@article{Nielen2026,
  author = {Nielen, Maaike and Svensson, Maria K and Furuland, Hans and Bonnevier, Ursa and Indurain, Ainhoa and Sedin, Annica and Eklund, Michael and Stenberg, Jenny},
  title = {Bioimpedance and Symptom Guided Fluid Management in Hemodialysis: A Multicenter Pre–Post Implementation Study},
  journal = {Hemodialysis International},
  year = {2026},
  doi = {10.1111/hdi.70109}
}
Kostenlos starten →